• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究多吡啶钌(II)配合物的电子结构与生物活性之间的关系。

Investigation of the Relationship between Electronic Structures and Bioactivities of Polypyridyl Ru(II) Complexes.

机构信息

Institute of Drug Discovery Technology (IDDT), Ningbo University, Ningbo 315211, China.

Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Department of Marine Pharmacy, College of Food and Pharmaceutical Sciences, Ningbo University, Ningbo 315800, China.

出版信息

Molecules. 2023 Jun 27;28(13):5035. doi: 10.3390/molecules28135035.

DOI:10.3390/molecules28135035
PMID:37446696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10343301/
Abstract

Ruthenium (Ru)-based organometallic drugs have gained attention as chemotherapeutic and bioimaging agents due to their fewer side effects and excellent physical optical properties. Tuning the electronic structures of Ru complexes has been proven to increase the cytotoxicity of cancer cells and the luminescent efficiency of the analytical probes. However, the relationship between electronic structures and bioactivities is still unclear due to the potential enhancement of both electron donor and acceptor properties. Thus, we investigated the relationship between the electronic structures of Ru(II) complexes and cytotoxicity by optimizing the electron-withdrawing (complex ), electron-neutral (complex ), and electron-donating (complex ) ligands through DFT calculations, bioactivities tests, and docking studies. Our results indicated that it was not sufficient to consider only either the effect of electron-withdrawing or electron-donating effects on biological activities instead of the total electronic effects. Furthermore, these complexes with electron-donating substituents (complex ) featured unique "off-on" luminescent emission phenomena caused by the various "HOMO-LUMO" distributions when they interacted with DNA, while complex with electron-withdrawing substituent showed an "always-on" signature. These findings offer valuable insight into the development of bifunctional chemotherapeutic agents along with bioimaging ability.

摘要

钌(Ru)基有机金属药物由于其副作用少和优异的物理光学性质而引起了人们的关注,可作为化疗药物和生物成像剂。事实证明,调节 Ru 配合物的电子结构可以提高癌细胞的细胞毒性和分析探针的发光效率。然而,由于电子给体和受体性质的潜在增强,电子结构和生物活性之间的关系仍不清楚。因此,我们通过 DFT 计算、生物活性测试和对接研究,优化了电子受主(复合物 )、电子中性(复合物 )和电子给体(复合物 )配体,研究了 Ru(II) 配合物的电子结构与细胞毒性之间的关系。结果表明,仅考虑电子受主或供体效应对生物活性的影响,而不考虑总电子效应是不够的。此外,这些具有供电子取代基的配合物(复合物 )与 DNA 相互作用时,由于不同的“HOMO-LUMO”分布,表现出独特的“关-开”发光发射现象,而具有吸电子取代基的配合物则表现出“常开”特征。这些发现为开发具有双重化疗和生物成像能力的双功能化疗药物提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/b9a7f966a106/molecules-28-05035-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/2332f3dc9f4b/molecules-28-05035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/e181619923d6/molecules-28-05035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/55b4b6a74abd/molecules-28-05035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/276a5852a318/molecules-28-05035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/86d01b9637b3/molecules-28-05035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/b9a7f966a106/molecules-28-05035-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/2332f3dc9f4b/molecules-28-05035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/e181619923d6/molecules-28-05035-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/55b4b6a74abd/molecules-28-05035-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/276a5852a318/molecules-28-05035-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/86d01b9637b3/molecules-28-05035-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c31d/10343301/b9a7f966a106/molecules-28-05035-sch001.jpg

相似文献

1
Investigation of the Relationship between Electronic Structures and Bioactivities of Polypyridyl Ru(II) Complexes.研究多吡啶钌(II)配合物的电子结构与生物活性之间的关系。
Molecules. 2023 Jun 27;28(13):5035. doi: 10.3390/molecules28135035.
2
Increasing the cytotoxicity of Ru(II) polypyridyl complexes by tuning the electron-donating ability of 1,10-phenanthroline ligands.通过调节 1,10-菲啰啉配体的供电子能力来提高 Ru(II) 多吡啶配合物的细胞毒性。
Dalton Trans. 2022 Nov 1;51(42):16224-16235. doi: 10.1039/d2dt02332f.
3
Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.Ru(II) 金属卟啉配合物源于四齿辅助配体,可有效进行光笼闭。
Acc Chem Res. 2018 Jun 19;51(6):1415-1421. doi: 10.1021/acs.accounts.8b00066. Epub 2018 Jun 5.
4
Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents.姜黄素双功能钌(ii)多吡啶配合物作为潜在的抗癌剂。
Dalton Trans. 2020 Jul 21;49(27):9454-9463. doi: 10.1039/d0dt01040e. Epub 2020 Jun 29.
5
DNA Binding Behavior, Sensor Studies, Antimicrobial, Photocleavage and In vitro Cytotoxicity of Synthesized Ru(II) Complexes with Assorted Intercalating Polypyridyl Ligands.合成的含多种嵌入型多吡啶配体的钌(II)配合物的DNA结合行为、传感器研究、抗菌性能、光裂解及体外细胞毒性
J Fluoresc. 2016 May;26(3):1101-13. doi: 10.1007/s10895-016-1800-9. Epub 2016 Apr 12.
6
Novel polypyridyl ruthenium complexes acting as high affinity DNA intercalators, potent transcription inhibitors and antitumor reagents.新型多吡啶钌配合物作为高亲和性 DNA 嵌入剂、强效转录抑制剂和抗肿瘤试剂。
J Inorg Biochem. 2018 Aug;185:1-9. doi: 10.1016/j.jinorgbio.2018.04.019. Epub 2018 May 2.
7
New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.新型含氟原子或呋喃基的钌多吡啶配合物的合成、DNA 结合、细胞毒性及抗肿瘤机制研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Feb 15;227:117534. doi: 10.1016/j.saa.2019.117534. Epub 2019 Oct 25.
8
Synthesis, Spectral Properties and DFT Calculations of new Ruthenium (II) Polypyridyl Complexes; DNA Binding Affinity and in Vitro Cytotoxicity Activity.新型钌(II)多吡啶配合物的合成、光谱性质及 DFT 计算;DNA 结合亲和力和体外细胞毒性活性。
J Fluoresc. 2017 Jul;27(4):1513-1530. doi: 10.1007/s10895-017-2091-5. Epub 2017 Apr 22.
9
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.Ru(II) 金属卟啉配合物作为单光子和双光子光动力治疗光敏剂的应用的关键综述。
Acc Chem Res. 2017 Nov 21;50(11):2727-2736. doi: 10.1021/acs.accounts.7b00180. Epub 2017 Oct 23.
10
Density functional theory/time-dependent DFT studies on the structures, trend in DNA-binding affinities, and spectral properties of complexes [Ru(bpy)2(p-R-pip)]2+ (R = -OH, -CH3, -H, -NO2).密度泛函理论/含时密度泛函理论对配合物[Ru(bpy)2(p-R-pip)]2+(R = -OH、-CH3、-H、-NO2)的结构、DNA结合亲和力趋势及光谱性质的研究
J Phys Chem A. 2006 Jul 6;110(26):8174-80. doi: 10.1021/jp0564389.

引用本文的文献

1
Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies.计算机辅助发现新型 SmDHODH 抑制剂用于血吸虫病治疗:基于配体的药物设计、分子对接、分子动力学模拟、类药性和 ADMET 研究。
PLoS Negl Trop Dis. 2024 Sep 12;18(9):e0012453. doi: 10.1371/journal.pntd.0012453. eCollection 2024 Sep.

本文引用的文献

1
Increasing the cytotoxicity of Ru(II) polypyridyl complexes by tuning the electron-donating ability of 1,10-phenanthroline ligands.通过调节 1,10-菲啰啉配体的供电子能力来提高 Ru(II) 多吡啶配合物的细胞毒性。
Dalton Trans. 2022 Nov 1;51(42):16224-16235. doi: 10.1039/d2dt02332f.
2
Novel biodegradable two-dimensional vanadene augmented photoelectro-fenton process for cancer catalytic therapy.新型可生物降解二维 vanadene 增强光芬顿工艺用于癌症催化治疗。
Biomaterials. 2022 Oct;289:121791. doi: 10.1016/j.biomaterials.2022.121791. Epub 2022 Sep 3.
3
How Computations Can Assist the Rational Design of Drugs for Photodynamic Therapy: Photosensitizing Activity Assessment of a Ru(II)-BODIPY Assembly.
计算如何辅助光动力治疗药物的合理设计:Ru(II)-BODIPY 组装物的光敏活性评估。
Molecules. 2022 Sep 1;27(17):5635. doi: 10.3390/molecules27175635.
4
Synthesis, photophysical properties and photo-induced cytotoxicity of novel tris(diazatriphenylene)ruthenium (II) complex.新型三(二氮杂芴)钌(II)配合物的合成、光物理性质及光诱导细胞毒性。
Bioorg Chem. 2022 Nov;128:106044. doi: 10.1016/j.bioorg.2022.106044. Epub 2022 Jul 28.
5
The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.基于 Ru(II)的光动力化疗试剂的发展。
Molecules. 2021 Sep 18;26(18):5679. doi: 10.3390/molecules26185679.
6
A photoactivatable chemotherapeutic Ru(II) complex bearing bathocuproine ligand efficiently induces cell death in human malignant melanoma cells through a multi-mechanistic pathway.一种光激活化疗钌(II)配合物,带有 bathocuproine 配体,通过多机制途径有效诱导人恶性黑色素瘤细胞死亡。
Chem Biol Interact. 2021 Oct 1;348:109644. doi: 10.1016/j.cbi.2021.109644. Epub 2021 Sep 8.
7
Ru(ii), Ir(iii), Re(i) and Rh(iii) based complexes as next generation anticancer metallopharmaceuticals.钌(ii)、铱(iii)、铼(i) 和铑(iii)基配合物作为下一代抗癌金属药物。
Dalton Trans. 2021 Aug 28;50(32):11259-11290. doi: 10.1039/d1dt01326b. Epub 2021 Aug 3.
8
Metallodrugs are unique: opportunities and challenges of discovery and development.金属药物独具特色:发现与开发的机遇与挑战
Chem Sci. 2020 Nov 12;11(48):12888-12917. doi: 10.1039/d0sc04082g.
9
The rediscovery of platinum-based cancer therapy.铂类抗癌疗法的再发现。
Nat Rev Cancer. 2021 Jan;21(1):37-50. doi: 10.1038/s41568-020-00308-y. Epub 2020 Oct 30.
10
Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities.强效半三明治型 Ru(Ⅱ) N^N(芳基-BIAN)配合物:溶酶体介导的细胞凋亡及体内外抗肿瘤活性。
Eur J Med Chem. 2020 Dec 1;207:112763. doi: 10.1016/j.ejmech.2020.112763. Epub 2020 Aug 22.